12 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/19/23 18:00
12/15/23
IMPLHealthDrugPharmaceutical PreparationsVivo Capital Viii, LLCCATS.m-740.12890-575-202,310I
1/4/23 18:46
12/31/22
IMPLHealthDrugPharmaceutical PreparationsLeaman John HaroldWAOChief FiM.d00.000117D
3/30/22 21:54
3/29/22
IMPLHealthDrugPharmaceutical PreparationsShrewsbury Stephen BWAOChief MeM.d481.970253498D
12/23/21 16:50
12/22/21
IMPLHealthDrugPharmaceutical PreparationsHoekman JohnWAOChief ScM.d331.6402018128D
11/22/21 17:05
11/19/21
IMPLHealthDrugPharmaceutical PreparationsNelson Timothy SWADP10810.76010New10D
9/22/21 16:57
9/21/21
IMPLHealthDrugPharmaceutical PreparationsShrewsbury Stephen BWAOChief MeM.d2002.72073New73D
8/19/21 17:23
8/18/21
IMPLHealthDrugPharmaceutical PreparationsAdams AdrianWADOCB,CEO,PP28013.99020New20D
4/29/21 21:10
4/27/21
IMPLHealthDrugPharmaceutical PreparationsVivo Capital Viii, LLCCATP.d8,62515.000575350I
4/29/21 20:51
4/27/21
IMPLHealthDrugPharmaceutical Preparations5Am Ventures V, L.P.CATP.d8,62515.000575New575I
4/29/21 19:45
4/27/21
IMPLHealthDrugPharmaceutical PreparationsNorwest Venture Partners Xiv, LPCATP.d12,37515.000825373,077D
4/29/21 18:44
4/27/21
IMPLHealthDrugPharmaceutical PreparationsVenbio Global Strategic Fund II L.P.CATP.d6,75015.000450192,760D
4/29/21 17:07
4/27/21
IMPLFinancInvAdvInvestment AdviceKkr Iris Investors LLCNYTP.d16,50015.0001,100413,803I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact